CareTrust CTRE SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Addition
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Addition at other companies
Other financials
Where this comes from
Reported directly by CareTrust in its filing.
Tagged under the XBRL concept ctre:SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateAddition.
The official record: CareTrust’s 10-K, filed February 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about CareTrust's sec schedule, 12-29, real estate companies, investment in mortgage loans on real estate, addition.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is CareTrust's SEC schedule, 12-29, real estate companies, investment in mortgage loans on real estate, addition?
- CareTrust (CTRE) reported SEC schedule, 12-29, real estate companies, investment in mortgage loans on real estate, addition of $32.97M in Q4 2025.
- How has CareTrust's SEC schedule, 12-29, real estate companies, investment in mortgage loans on real estate, addition changed year-over-year?
- CareTrust's SEC schedule, 12-29, real estate companies, investment in mortgage loans on real estate, addition decreased by 76.4% year-over-year, from $139.45M to $32.97M.
- What is the long-term trend for CareTrust's SEC schedule, 12-29, real estate companies, investment in mortgage loans on real estate, addition?
- Over 2 years (2023 to 2025), CareTrust's SEC schedule, 12-29, real estate companies, investment in mortgage loans on real estate, addition has grown at a 55.9% compound annual growth rate (CAGR), from $54.22M to $131.86M.
- What does SEC schedule, 12-29, real estate companies, investment in mortgage loans on real estate, addition mean?
- Represents the total gross additions to the company's portfolio of mortgage loans on real estate during the reporting period. This includes new loan originations, acquisitions of existing loans, and additional funding provided to existing borrowers. It serves as a key indicator of the company's capital deployment strategy within its debt investment business.